argenx SE
phase advance study conclusions | argenx SE
Company
Deck Type
Sector
Industry
Deck date
December 2022
Slide
14 of 15
Related slides by other companies
RenovoRx
IPO
August 2021
designed for success one phase trial to approval pivotal tiger pac phase study schema currently enrolling | RenovoRx
Aeglea BioTherapeutics
Investor Presentation
October 2023
combination programs summary wot | Aeglea BioTherapeutics
Dare Bioscience
Investor Presentation
July 2023
cream phase respond study overview | Dare Bioscience
BioAtla
Investor Presentation
January 2024
cab phase mono and study currently underway | BioAtla
Other recent decks by argenx SE
See all presentations (28 decks)
Results
February 2024
Investor Conference
January 2024
Investor Presentation
December 2023
Investor Presentation
November 2023
Search Thousands of Presentations by World Leading Companies
Trending:
Addressable Market
Ecosystem
Beauty Market
WACC
NFT
Management Team
Investment Highlights

Stay in the loop

Join our mailing list to stay in the loop with updates and newest feature releases

Presentations

Start Up
IPO
SPAC
M&A
Investor Day
Results
ESG
Credit
Investment Banking

Explore

Presentation Collections
Slide Collections

Company

Blog
Contact us
© 2021-2023 Slidebook.io